[Federal Register Volume 66, Number 197 (Thursday, October 11, 2001)]
[Notices]
[Page 51970]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-25444]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 26, 2001, Noramco, Inc., 
1440 Olympic Drive, Athens, Georgia 30601, made application by renewal 
to the Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to support its other manufacturing facility with 
manufacturing and analytical testing.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than December 10, 2001.

    Dated: October 02, 2001.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 01-25444 Filed 10-10-01; 8:45 am]
BILLING CODE 4410-09-M